What role do the body microbiota play in augmenting/neutralizing infection intensity in patients suffering from COVID-19? Do SARS-CoV-2 negate the competition from other viral and bacterial strains already present in the patient's body and vice versa? Is there a link between mild to moderate versus severe symptom development among people who have contracted the virus and the presence of specific microbial load in them, apart from their own physiology and genetics? Has there been any research on the possible effect of other influenza virus sub types (mostly B) on SARS-CoV-2? How much does the presence of a diverse microflora influence the onset of cytokine storm in case of infection by a foreign pathogen?

More Abhishek Mukherjee's questions See All
Similar questions and discussions